Fluor

United Statesfluor.com

Fluor Corporation (Fluor) is a U.S.-based, publicly traded engineering, procurement and construction (EPC) company headquartered in Irving, Texas. Founded in 1912, the company delivers complex capital projects for clients worldwide across energy, chemicals, infrastructure, mining and metals, government and industrial markets.

For the chemical industry, Fluor provides end-to-end services spanning studies and front-end engineering design (FEED) through EPC, commissioning, start-up, and operations and maintenance. Its portfolio includes petrochemical and polymer units, downstream refining and aromatics, fertilizers, specialty chemicals, and emerging low‑carbon and circular chemistry projects such as hydrogen, carbon capture and bio-based fuels. Fluor utilizes global engineering centers, supply chain management, modularization and fabrication capabilities to execute large-scale, multi-unit sites and debottlenecking, as well as brownfield revamps and turnarounds.

Also known as Fluor Corporation.

Projects Fluor is involved in

chemXplore tracks 24 projects involving Fluor, of which 13 are active.

Fluor's role on them: FEED, EPC, EPCI, EPCM, PMC / Owner's engineer, and Pre-FEED / FEL study.

5 Announced / Concept 5 FEED / Pre-FID 3 Under Construction

10 new construction and 3 expansion.

Expected to start operating
2026
none
2027
4 projects
2028
none
2029
3 projects
2030
3 projects
2031
none

1 of the active projects carry no start-up date yet.

What moved recently
  • 21 July 2026 GPIC Aromatics Facility Expansion, Sitra, Bahrain · FEED / Pre-FID · Bahrain
  • 6 May 2026 Eli Lilly Lebanon Indiana Manufacturing Expansion · Announced / Concept · United States
  • April 2026 Perpetual Next Southeast US Biomethanol Facilities · FEED / Pre-FID · United States
  • March 2026 Blue Circle Olefins Rotterdam Methanol to Olefins Facility · FEED / Pre-FID · The Netherlands
  • March 2026 BASF Zhanjiang Verbund Site new construction · Operational / Completed · China

Contractors, licensors, and offtakers are recorded on all 13 of them For subscribers

Targeting: Methanol (5), EVOH (Ethylene vinyl-alcohol copolymer) (2), Benzene (1), Carbon dioxide (1), Ethylene (1), Orforglipron (1)

Follow these projects in chemXplore →

Latest news on Fluor

5 October 2026
Perpetual Next and Lhyfe sign MoU to explore renewable hydrogen supply for DeltaNor biomethanol in Delfzijl

MoU to assess local renewable hydrogen supply for a planned Delfzijl biomethanol plant, targeting roughly 12,000 tonnes H2 per year to boost biomethanol yields.

29 September 2026
JGC-Fluor JV receives NTP for LNG Canada Phase 2 after FID

Notice to Proceed issued for LNG Canada Phase 2 after FID; contract mainly lump-sum with some cost-plus; JGC to recognise US$7.5bn in fiscal 2026 after FEED update.

29 September 2026
Fluor JV with JGC Selected for LNG Canada Phase 2 After FID

Notice to proceed issued; US$7.5bn share to be recognized in Q3 FY2026; Phase 2 adds one storage tank and two trains, doubling output to ~28 Mtpa.

14 September 2026
Perpetual Next appoints Bilfinger for Delfzijl biomethanol project

Appointment advances DeltaTorr/DeltaNor toward FID for a biomethanol plant converting biogenic residual streams, with up to €1 billion capital at stake.

3 September 2026
Perpetual Next and PreZero Netherlands to supply waste wood for biomethanol and biomethane

Low‑grade waste wood will be routed to Dutch biomethanol and biomethane plants to secure feedstock for scalable production.

7 August 2026
Fluor Corporation second-quarter 2026 results

Revenue rose 9% to $4.3B; new awards $6.1B and backlog $26.9B; adjusted EBITDA guidance narrowed and reduced; $300M returned to shareholders in Q2.

6 August 2026
ORLEN Group posts record Q2 2026 profits and PLN 14.7bn H1 capex

Q2 results: revenue PLN 76.5bn, LIFO EBITDA PLN 13.9bn, net profit PLN 7.7bn; record foreign retail profits and H1 capital expenditure PLN 14.7bn.

5 August 2026
Eli Lilly Q2 2026 results: revenue +48%, raises guidance; retatrutide package complete

Revenue rose 48% to $23.0bn driven by Mounjaro and Zepbound; updated 2026 revenue guidance to $85–87bn; retatrutide Phase 3 package complete supporting a Q1 2027 BLA.

Where its projects are

By country, the most active first. active / all projects

The 8 with the most active projects, of 12 countries.